Diseases of the circulatory system for many decades has a leading position in the structure of morbidity. At present, many experts are pinning their hopes on reducing mortality from cardiovascular diseases with statin use. Justified if their hopes?
This analysis is devoted to consumption of Russian patients with statins.
The target audience of the analysis are cardiologists, internists, vascular surgeons, lipidology, pharmaceutical workers, decision-makers about the drug provision, farmakoekonomisty, experts in health economics, employees of pharmaceutical companies, distributors, agents, and many other stakeholders.